Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 19, Issue 3, 2010, Pages 963-976

  Canu, Elisa ^a   McLaren, Donald G ^b,c,d   Fitzgerald, Michele E ^b,d   Bendlin, Barbara B ^b,d   Zoccatelli, Giada ^e   Alessandrini, Franco ^e   Pizzini, Francesca B ^e   Ricciardi, Giuseppe K ^e   Beltramello, Alberto ^e   Johnson, Sterling C ^b,d   Frisoni, Giovanni B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e MAGGIORE HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Diffusion weighted imaging; Fractional anisotropy; Mean diffusivity; Microstructure

Indexed keywords

AGED; ALZHEIMER DISEASE; ANISOTROPY; ANTERIOR COMMISSURE; ARTICLE; BRAIN REGION; BRAIN SIZE; CAPSULA INTERNA; CEREBELLUM; CEREBRAL PEDUNCLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOPONTINE TRACT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; INFERIOR TEMPORAL LOBE; MALE; PRIORITY JOURNAL; SPLENIUM; STRUCTURE ANALYSIS; TEMPORAL CORTEX; THALAMUS; VOLUMETRY; WHITE MATTER;

EID: 77149157505     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1295     Document Type: Article

References (69)

1. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60, 393-398.
2. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R (1990) MR signal abnormalities in memory disorder and dementia. AJNR Am J Neuroradiol 11, 283-290. (Pubitemid 20155062)
3. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W (1995) Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45, 883-888.
4. Vermersch P, Roche J, Hamon M, Daems-Monpeurt C, Pruvo JP, Dewailly P, Petit H (1996) White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy. J Neurol 243, 231-234.
5. Kantarci K, Jack CR, Jr., Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2001) Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 219, 101-107.
6. Rose SE, McMahon KL, Janke AL, O'Dowd B, de Zubicaray G, StrudwickMW, Chalk JB (2006) Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 77, 1122-1128.
7. Beaulieu C (2002) The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 15, 435-455.
8. Basser PJ, Pierpaoli C (1996) Microstructural and physiological features of tissues elucidated by quantitative-diffusiontensor MRI. J Magn Reson B 111, 209-219.
9. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996) Diffusion tensor MR imaging of the human brain. Radiology 201, 637-648.
10. Bronge L, Bogdanovic N, Wahlund LO (2002) Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 13, 205-212.
11. Englund E (1998) Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9 Suppl 1, 6-12.
12. Moseley M (2002) Diffusion tensor imaging and aging - a review. NMR Biomed 15, 553-560. (Pubitemid 36054515)
13. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR, Jr. (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64, 902-904.
14. Allen G, Barnard H, McColl R, Hester AL, Fields JA,Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM(2007) Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol 64, 1482-1487.
15. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M (2002) White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72, 742-746.
16. Choi SJ, Lim KO, Monteiro I, Reisberg B (2005) Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J Geriatr Psychiatry Neurol 18, 12-19.
17. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K(1998) Diffusion-weightedMRimaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci 156, 195-200.
18. Naggara O, Oppenheim C, Rieu D, Raoux N, Rodrigo S, Dalla Barba G, Meder JF (2006) Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res 146, 243-249.
19. Sandson TA, Felician O, Edelman RR, Warach S (1999) Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 10, 166-171.
20. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P (2004) Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 18, 101-108.
21. Medina D, DeToledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, Bennett DA, Leurgans S, Turner DA, Stebbins GT (2006) White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 27, 663-672.
22. Rose SE, Janke AL, Chalk JB (2008) Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study. J Magn Reson Imaging 27, 20-26.
23. Xie S, Xiao JX, Gong GL, Zang YF,Wang YH,Wu HK, Jiang XX (2006) Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 66, 1845-1849.
24. Salat DH, Tuch DS, Hevelone ND, Fischl B, Corkin S, Rosas HD, Dale AM (2005) Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci 1064, 37-49. (Pubitemid 43030947)
25. Abe O, Yamasue H, Aoki S, Suga M, Yamada H, Kasai K, Masutani Y, Kato N, Ohtomo K (2008) Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol Aging 29, 102-116.
26. Fjell AM,Westlye LT, Greve DN, Fischl B, Benner T, van der Kouwe AJ, Salat D, Bjornerud A, Due-Tonnessen P,Walhovd KB (2008) The relationship between diffusion tensor imaging and volumetry as measures of white matter properties. Neuroimage 42, 1654-1668.
27. Hayakawa N, Kato H, Araki T (2007) Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector. Mech Ageing Dev 128, 311-316.
28. Hugenschmidt CE, Peiffer AM, Kraft RA, Casanova R, Deibler AR, Burdette JH, Maldjian JA, Laurienti PJ (2008) Relating imaging indices of white matter integrity and volume in healthy older adults. Cereb Cortex 18, 433-442.
29. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L,Wood F, Maldjian JA (2007) Biological parametric mapping: A statistical toolbox for multimodality brain image analysis. Neuroimage 34, 137-143.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
31. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414.
32. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
33. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488.
34. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26, 839-851.
35. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38, 95-113.
36. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, Matthews PM, Brady JM, Smith SM (2003). Magn Reson Med 50, 1077-1088.
37. Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5, 143-156.
38. Fellgiebel A, Muller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, Stoeter P (2005) Color-coded diffusion-tensorimaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging 26, 1193-1198.
39. Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD (2008) White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging, in press.
40. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW (2007) Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 68, 13-19.
41. Camara E, Bodammer N, Rodriguez-Fornells A, Tempelmann C (2007) Age-related water diffusion changes in human brain: a voxel-based approach. Neuroimage 34, 1588-1599.
42. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM (2000) Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69, 528-530.
43. Teipel SJ, Stahl R, Dietrich O, Schoenberg SO, Perneczky R, Bokde AL, Reiser MF, Moller HJ, Hampel H (2007) Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 34, 985-995. (Pubitemid 46394457)
44. Honig LS, Mayeux R (2001) Natural history of Alzheimer's disease. Aging (Milano) 13, 171-182.
45. Braak H, Braak E (1990) Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49, 215-224.
46. Suva D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J (1999) Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58, 1125-1134.
47. Golaz J, Bouras C, Hof PR (1992) Motor cortex involvement in presenile dementia: report of a case. J Geriatr Psychiatry Neurol 5, 85-92.
48. Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR (1990) Focal Alzheimer's disease. Neurology 40, 14-19.
49. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873.
50. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 65, 710-724.
51. Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol Psychiatry 35, 480-487.
52. Frisoni GB, Prestia A, Rasser PE, Bonetti M, Thompson PM (2009) In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. J Neurol 256, 916-924.
53. de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, de Bruin PW, Middelkoop HA, van Buchem MA, van der Grond J (2008) Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 131, 3277-3285.
54. Ferrarini L, Palm WM, Olofsen H, van der Landen R, Jan Blauw G, Westendorp RG, Bollen EL, Middelkoop HA, Reiber JH, van Buchem MA, Admiraal-Behloul F (2008) MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease. Neuroimage 39, 1832-1838.
55. Busatto GF, Diniz BS, Zanetti MV (2008) Voxel-based morphometry in Alzheimer's disease. Expert Rev Neurother 8, 1691-1702.
56. Chaim TM, Duran FL, Uchida RR, Perico CA, de Castro CC, Busatto GF (2007) Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxelbased morphometry. Psychiatry Res 154, 59-68.
57. Stoub TR, deToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC (2006) Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 103, 10041-10045.
58. Villain N, Desgranges B, Viader F, de la Sayette V, Mezenge F, Landeau B, Baron JC, Eustache F, Chetelat G (2008) Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci 28, 6174-6181.
59. Peters A, Moss MB, Sethares C (2000) Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J Comp Neurol 419, 364-376. (Pubitemid 30134146)
60. Peters A, Sethares C (2002) Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J Comp Neurol 442, 277-291.
61. Wozniak JR, Lim KO (2006) Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 30, 762-774.
62. Brun A, Gustafson L, Englund E (1990) Subcortical pathology of Alzheimer's disease. Adv Neurol 51, 73-77.
63. Iwamoto N, Nishiyama E, Ohwada J, Arai H (1997) Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels. Acta Neuropathol 93, 334-340.
64. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY (2001) Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21, RC118.
65. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800.
66. Wischik CM, Bentham P, Wischik DJ, Seng KM (2008) O3-04-07: Tau aggregation inhibitor (TAI) therapy with remberTM arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks. Alzheimers Dement 4 (Suppl 4), T167.
67. Higuchi M, LeeVM,Trojanowski JQ (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2, 131-150.
68. Lee VM, Daughenbaugh R, Trojanowski JQ (1994) Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging 15 Suppl 2, S87-89.
69. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403-408.